A resistance line has formed in the chart of Aflac Inc . (NYSE:AFL). The stock has approached this line a few times since the summer. If it finally breaks through, a breakout is expected. Read more to learn how to profit from this trade.Aflac Inc. (AFL) offers supplemental health insurance and life insurance in the two largest insurance markets in the world, the U.S. and Japan. In addition to its cancer policies, the company has broadened its product offerings to include accidents, disability, and long-term-care insurance.
The company’s U.S segment is set up for growth due to its buyout of Argus Dental and Vision as well as Zurich North America's U.S. Corporate Life and Pensions business. AFL should also benefit from a strong product pipeline this year and cost-cutting initiatives.
AFL’s debt-to-equity ratio of 0.2 indicates it is on solid financial footing. The company has grown earnings an average of 14.4% per year over the past five years, but earnings are down 7.1% over the past year. However, analysts expect earnings to rise 18.7% year over year in the current quarter.